IVF centre in Goa
Consultations in Panjim · Margao · Mapusa · Vasco
Call
Page 66 of 73Doctor path · Doctors' Textbook
Part B: IVF programme · Day OB-6
Page 66 of 73

Genetic testing of embryos for the clinician

On this page you will learn

Three kinds of PGT

PGT tests a few cells from an IVF embryo before transfer. There are three kinds, and they answer different questions:

The ESHRE PGT Consortium published its good practice papers in 2020: one on organising a PGT service, one on biopsy, and one each on the testing methods.

Source: 2020, ESHRE PGT Consortium, Human Reproduction Open hoaa021 - ESHRE PGT Consortium good practice recommendations for the organisation of PGT

The clinician's part

The lab biopsies the embryo and the genetics laboratory tests it. Your part is everything around that:

ESHRE's organisation paper sets out the counselling: the steps, the limits, the chance that no embryo is suitable for transfer, and follow-up of the pregnancy and child.

Source: 2020, ESHRE PGT Consortium, Human Reproduction Open hoaa021 - ESHRE PGT Consortium good practice recommendations for the organisation of PGT

The lab part, in one paragraph

At the blastocyst stage the embryologist removes a few cells from the outer layer, which will become the placenta, and sends them to a genetics laboratory. The inner cell mass, which forms the baby, is not touched. The embryo is usually vitrified. You do not need the biopsy technique; you need to know that the sample is small, and that a small sample can mislead.

Source: 2020, ESHRE PGT Consortium and SIG Embryology, Human Reproduction Open hoaa020 - ESHRE PGT Consortium and SIG Embryology good practice recommendations for polar body and embryo biopsy for PGT

Limits of PGT-A

PGT-A sounds like a way to pick the "right" embryo. The evidence is more modest. ESHRE does not recommend PGT-A for routine use; in recurrent implantation failure it says PGT-A can be considered.

Source: 2023, ESHRE Add-ons Working Group, Human Reproduction 38(11):2062-2104 - Good practice recommendations on add-ons in reproductive medicine

Source: 2023, ESHRE Working Group on Recurrent Implantation Failure (Cimadomo et al.), Human Reproduction Open hoad023 - ESHRE good practice recommendations on recurrent implantation failure

PGT-A cannot make an embryo better. All it can do is help choose among embryos the couple already has.

The law in India

Section 25 of the ART Act says PGT shall be used to screen embryos for known, pre-existing, heritable or genetic diseases only. Read it with the current rules and National Board guidance before offering PGT for any other reason, and follow the clinic's written policy.

Source: 18 Dec 2021, Government of India (Act No. 42 of 2021) - The Assisted Reproductive Technology (Regulation) Act, 2021 (section 25)

Section 26 of the same Act, read with the PCPNDT Act, forbids offering a child of a chosen sex and any act to identify the sex of an embryo, except to diagnose, prevent or treat a sex-linked disease. No report, conversation or note may reveal the sex of an embryo for any other reason. Advertising such a service is itself an offence.

Source: 18 Dec 2021, Government of India (Act No. 42 of 2021) - The Assisted Reproductive Technology (Regulation) Act, 2021 (sections 26 and 32)

Source: 1994, Government of India (Act No. 57 of 1994) - The Pre-Conception and Pre-Natal Diagnostic Techniques Act, 1994 (PCPNDT Act, as amended)

At the clinic

On Day OB-6 the faculty discusses PGT counselling with you on an anonymised case: the indication, what to say about limits, and the legal points. Ultrasound scans are watched only: no trainee holds the probe on a patient (PCPNDT Act).

The lab side

Basic picture only: biopsy at the blastocyst stage, freezing while results are awaited, and careful labelling so every result matches its embryo. You see this on the lab screen if a biopsy is scheduled; you do not handle embryos.

Common mistakes

Key points

Check yourself

Answer in your head first, then tap a question to see a short answer. Full model answers are in the faculty guidebook.

1. What is the difference between PGT-M, PGT-SR and PGT-A?

PGT-M tests for a known single-gene condition, PGT-SR for a parent's structural chromosome change, PGT-A for chromosome number.

2. What does section 25 of the ART Act say about PGT?

It shall be used to screen embryos for known, pre-existing, heritable or genetic diseases only.

3. Why does ESHRE not recommend PGT-A routinely?

Trials have not shown a higher live birth per started cycle for all patients, mosaic and false results occur, and it adds cost and biopsy.

4. What must every PGT couple be told before starting?

The steps, that not every embryo can be diagnosed, the chance of no transferable embryo, error risk, and confirmation in pregnancy.

5. What does Indian law forbid around embryo sex?

Telling or choosing the sex of an embryo, except to diagnose, prevent or treat a sex-linked disease.

6. From page 53: which part of the blastocyst forms the baby and which forms the placenta?

The inner cell mass forms the baby; the outer layer (trophectoderm) forms the placenta.

Training note. Training content for registered medical practitioners. Trainees observe all patient care; they do not treat patients during the programme.

Contents and reading plan

Questions on this page

Is PGT-A recommended for every IVF couple?

No. ESHRE does not recommend PGT-A for routine use.

Can PGT be used to know an embryo's sex?

No. Indian law forbids it except to diagnose, prevent or treat a sex-linked disease.

The Genesis Doctors' Textbook is teaching text for registered medical practitioners on the doctor programmes of the Genesis ART Training Academy. It is not treatment advice and gives no medicine doses; trainees observe all patient care, ultrasound scans are watched only (PCPNDT Act), and bench skills are practised under supervision. Page numbers never change.